Expression of tight junction molecules in breast carcinomas analysed by array PCR and immunohistochemistry

Pathology and Oncology Research

Volumn 18, Issue 3, 2012, Pages 593-606

  Tökés, Anna Mária ^a   Szász, Attila Marcell ^a   Juhász, Éva ^a   Schaff, Zsuzsa ^a   Harsányi, László ^a   Molnár, István Arthur ^a   Baranyai, Zsolt ^b   Besznyák Jr , István ^b   Zaránd, Attila ^b   Salamon, Ferenc ^b   Kulka, Janina ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Uzsoki Memorial Hospital   (Hungary)

Author keywords

Array; Breast carcinoma; Claudin; Immunohistochemistry; Tight junction

Indexed keywords

ALPHA CATENIN; CLAUDIN; CLAUDIN 10; CLAUDIN 16; CLAUDIN 17; CLAUDIN 18; CLAUDIN 19; CLAUDIN 5; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; JUNCTIONAL ADHESION MOLECULE B; MEMBRANE PROTEIN; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN ZO1; PROTEIN ZO2; PROTEINASE ACTIVATED RECEPTOR 3 PARTITIONING DEFECTIVE 3 HOMOLOG; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CLDN 10 GENE; CLDN 16 GENE; CLDN 17 GENE; CLDN 18 GENE; CLDN 5 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CTNNAL1 GENE; DOWN REGULATION; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAM-B GENE; PARD3 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION; ZO 1 GENE; ZO 2 GENE;

EID: 84863989695     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9481-9     Document Type: Article

References (46)

1. Brennan K, Offiah G, McSherry EA et al (2010) Tight junctions: a barrier to the initiation and progression of breast cancer? J Biomed Biotechnol. doi:10-1155/2010/460607
2. Gonzalez-Mariscal L, Betanzos A, Nava P et al (2003) Tight junction proteins. Progr Biophys Mol Biol 81:1-44
3. Gonzalez-Mariscal L, Lechuga S, Garay E (2007) Role of tight junctions in cell proliferation and cancer. Progr HistochemCytochem 42:1-57
4. Lelievre SA (2010) Tissue polarity-dependent control of mammary epithelial homeostasis and cancer development: an epigenetic perspective. J Mammary Gland Biol Neoplasia 15:49-63
5. Alroy J (1979) Tight junctions adjacent to tumor stromal interface in human invasive transitional cell carcinomas. Virchows Arch 30:289-296
6. Martinez-Palomo A (1970) Ultrastructural modifications of intercellular junctions between tumor cells. In Vitro 6:15-20
7. Martinez-Palomo A (1970) Ultrastructural modifications of intercellular junctions in some epithelial tumors. Lab Investig 22:605-614
8. Hough CD, Sherman-Baust CA, Pizer ES et al (2000) Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60:6281-6287
9. Hoevel T, Macek R, Mundigl O et al (2002) Expression and targeting of the tight junction protein CLDN1 in CLDN1- negative human breast tumor cells. J Cell Physiol 191:60-68
10. Hoevel T, Macek R, Swisshelm K et al (2004) Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer 108:374-383
11. Kominsky SL, Argani P, Korz D et al (2003) Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22:2021-2033
12. Kramer F, White K, Kubbies M et al (2000) Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Human Genet 107:249-256
13. Sobel G, Paska C, Szabo I et al (2005) Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Human Pathol 36:162-169
14. Sobel G, Nemeth J, Kiss A et al (2006) Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. Gynecol Oncol 103:591-598
15. Blanchard AA, Skliris GP, Watson PH et al (2009) Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch 454:647-656
16. Erin N, Wang N, Xin P et al (2009) Altered gene expression in breast cancer liver metastases. Int J Cancer 124:1503-1516
17. Hewitt KJ, Agarwal R, Morin PJ (2006) The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6:186
18. Kim TH, Huh JH, Lee S et al (2008) Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology 53:48-55
19. Kulka J, Szasz AM, Nemeth Z et al (2005) Expression of tight junction protein claudin-4 in basal-like breast carcinomas. Pathol Oncol Res 15:59-64
20. Lanigan F, McKiernan E, Brennan DJ et al (2009) Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 124:2088-2097
21. Osanai M, Murata M, Nishikiori N et al (2007) Occludin-mediated premature senescence is a fail-safe mechanism against tumorigenesis in breast carcinoma cells. Cancer Sci 98:1027-1034
22. Tokes AM, Kulka J, Paku S et al (2005) Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7:296-305
23. Martin TA, Harrison GM, Watkins G et al (2008) Claudin-16 reduces the aggressive behavior of human breast cancer cells. J Cell Biochem 105:41-52
24. Naik MU, Naik TU, Suckow AT et al (2008) Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 68:2194-2203
25. Naik UP, Naik MU (2008) Putting the brakes on cancer cell migration: JAM-A restrains integrin activation. Cell Adh Migr 2:249-251
26. Morohashi S, Kusumi T, Sato F et al (2007) Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int J Mol Med 20:139-143
27. Creighton CJ, Li X, Landis M et al (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumorinitiating features. PNAS 106:13820-13825
28. Herschkowitz JI, Simin K, Weigman VJ et al (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8:R76
29. Prat A, Perou CM (2009) Mammary development meets cancer genomics. Nat Med 15:842-844
30. Prat A, Perou CM (2011) Deconstructing the molecular portraits of breast cancer. Mol Oncol 5:5-2331
31. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747-752
32. Escudero-Esparza A, Jiang WG, Martin TA (2011) The Claudin family and its role in cancer and metastasis. Front Biosci 1:1069-1083
33. Turksen K, Troy TC (2011) Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta 1:73-79
34. Dahiya N, Becker KG, Wood WH et al (2011) Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion. PLoS One 6:e22119
35. Amasheh S, Meiri N, Gitter AH et al (2002) Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115:4969-4976
36. Amasheh S, Schmidt T, Mahn M et al (2005) Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 321:89-96
37. Nguyen DA, Neville MC (1998) Tight junction regulation in the mammary gland. J Mammary Gland Biol Neoplasia 3:233-246
38. Schulzke JD, Fromm M (2009) Tight junctions: molecular structure meets function. Ann NY Acad Sci 1165:1-6
39. Tsukita S, Furuse M (2000) The structure and function of claudins, cell adhesion molecules at tight junctions. Ann NY Acad Sci 915:129-135
40. Turunen M, Talvensaari-Mattila A, Soini Y et al (2009) Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Anticancer Res 29:5185-5189
41. Szasz A, Tokes A, Micsinai MJ et al (2011) Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis. Clin Exp Metastasis 28:55-63
42. Nemeth Z, Szasz AM, Tatrai P et al (2009) Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers. J Histochem Cytochem 57:113-121
43. Sanada Y, Oue N, Mitani Y et al (2006) Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 208:633-642
44. Hou J, Renigunta A, Gomes AS et al (2009) Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. PNAS 106:15350-15355
45. Zen K, Yasui K, Gen Y et al (2009) Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma. Oncogene 28:2910-2918
46. Ding L, Ellis MJ, Li S et al (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464:999-1005